Observational Study on Clinical Practice in the Management of Ulcerative Colitis with Oral 5-Aminosalicylic Acid in Japan
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms OPTIMUM
- Sponsors Kyorin Pharmaceutical
- 22 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Sep 2012 Actual initiation date (29 Aug 2012) added as reported by University Hospital Medical Information Network - Japan.